Publications for Nirupama Verma
Publications for Nirupama Verma
2011
2016
Hall, B., Verma, N., Tran, G., Hodgkinson, S.
(2011). Distinct regulatory CD4+T cell subsets;
differences between naïve and antigen specific T
regulatory cells. Current Opinion in
Immunology, 23(5), 641-647. <a
href="http://dx.doi.org/10.1016/j.coi.2011.07.01
2">[More Information]</a>
Seldon, T., Pryor, R., Palkova, A., Jones, M.,
Verma, N., Findova, M., Braet, K., Sheng, Y.,
Fan, Y., Zhou, E., Fromm, P., Silveira, P.,
Elgundi, Z., Ju, X., Clark, G., Bradstock, K.,
Hart, D., et al (2016). Immunosuppressive
human anti-CD83 monoclonal antibody
depletion of activated dendritic cells in
transplantation. Leukemia, 30(3), 692-700. <a
href="http://dx.doi.org/10.1038/leu.2015.231">[
More Information]</a>
2014
Verma, N., Hall, B., Plain, K., Robinson, C.,
Boyd, R., Tran, G., Wang, C., Bishop, A.,
Hodgkinson, S. (2014). Interleukin-12
(IL-12p70) Promotes Induction of Highly Potent
Th1-Like CD4(+)CD25(+) T Regulatory Cells
That Inhibit Allograft Rejection in Unmodified
Recipients. Frontiers in Immunology, 5, 1-11. <a
href="http://dx.doi.org/10.3389/fimmu.2014.001
90">[More Information]</a>
2013
Plain, K., Verma, N., Tran, G., Nomura, M.,
Boyd, R., Robinson, C., Hodgkinson, S., Hall, B.
(2013). Cytokines affecting CD4+ T regulatory
cells in transplant tolerance. Interleukin-4 does
not maintain alloantigen specific CD4+CD25+
Treg. Transplant Immunology, 29, 51-59. <a
href="http://dx.doi.org/10.1016/j.trim.2013.10.00
3">[More Information]</a>
Hall, B., Tran, G., Verma, N., Plain, K.,
Robinson, C., Nomura, M., Hodgkinson, S.
(2013). Do natural T regulatory cells become
activated to antigen specific T regulatory cells in
transplantation and in autoimmunity? Frontiers
in Immunology, 4, 208. <a
href="http://dx.doi.org/10.3389/fimmu.2013.002
08">[More Information]</a>
2012
Tran, G., Hodgkinson, S., Carter, N., Verma, N.,
Plain, K., Boyd, R., Robinson, C., Nomura, M.,
Killingsworth, M., Hall, B. (2012). IL-5
promotes induction of antigen-specific
CD4+CD25+T regulatory cells that suppress
autoimmunity. Blood, 119(19), 4441-4450. <a
href="http://dx.doi.org/10.1182/blood-2011-12-3
96101">[More Information]</a>
Jeet, V., Russell, P., Verma, N., Khatri, A.
(2012). Targeting aurora kinases: a novel
approach to curb the growth & chemoresistance
of androgen refractory prostate cancer. Current
Cancer Drug Targets, 12(2), 144-163. <a
href="http://dx.doi.org/10.2174/1568009127990
95180">[More Information]</a>
Verma, N., Tran, G., Hodgkinson, S., Plain, K.,
Bishop, A., Boyd, R., Robinson, C., Wang, C.,
Hall, B. (2011). IL-12p70 induces IL-2
alloactivated CD4+CD25+ Treg to Th1 like Treg
that suppress fully allogeneic graft rejection. 41st
Australasian Society for Immunology Annual
Meeting, N/A: N/A.
Tran, G., Hodgkinson, S., Carter, N.,
Killingsworth, M., Nomura, M., Verma, N.,
Plain, K., Boyd, R., Robinson, C., Hall, B.
(2011). IL-5 therapy prevents autoimmune
demyelination by promotion of IL-4 activated
antigen specific Treg. 41st Australasian Society
for Immunology Annual Meeting, N/A: N/A.
Tran, G., Hodgkinson, S., Carter, N., Verma, N.,
Robinson, C., Plain, K., Boyd, R., Hall, B.
(2011). In vitro induction of antigen specific
CD4+CD25+ Tregulatory cells that prevent
autoimmune mediated demyelination. 41st
Australasian Society for Immunology Annual
Meeting, N/A: N/A.
Singh, P., Joshi, S., Russell, P., Verma, N.,
Wang, X., Khatri, A. (2011). Molecular
chemotherapy and chemotherapy: a new front
against late-stage hormone-refractory prostate
cancer. Clinical Cancer Research, 17(12),
4006-4018. <a
href="http://dx.doi.org/10.1158/1078-0432.CCR11-0248">[More Information]</a>
2010
Tran, G., Hodgkinson, S., Carter, N.,
Killingsworth, M., Nomura, M., Verma, N.,
Plain, K., Boyd, R., Hall, B. (2010). Membrane
attack complex of complement is not essential
for immune mediated demyelination in
experimental autoimmune neuritis. Journal of
Neuroimmunology, 229(1-2), 98-106. <a
href="http://dx.doi.org/10.1016/j.jneuroim.2010.
07.010">[More Information]</a>
2009
Verma, N., Plain, K., Nomura, M., Tran, G.,
Robinson, C., Boyd, R., Hodgkinson, S., Hall, B.
(2009). CD4+CD25+T cells alloactivated ex
vivo by IL-2 or IL-4 become potent
alloantigen-specific inhibitors of rejection with
different phenotypes, suggesting seperate
pathways of activation by Th1 and Th2
responses. Blood, 113(2), 479-487. <a
Publications for Nirupama Verma
href="http://dx.doi.org/10.1182/blood-2008-05-1
56612">[More Information]</a>
2008
Verma, N., Plain, K., Nomura, M., Tran, G.,
Robinson, C., Boyd, R., Hodgkinson, S., Hall, B.
(2008). IL-2 or IL-4 activated CD4+CD25+T
cells in MLC become antigen specific and
respectively express IFN-y receptor (R) or
IL-5Ra. Keystone Symposia conference
"Tolerance in transplantation and
Autoimmunity", Colorado, USA: Keystone
Symposia.
Hall, B., Robinson, C., Plain, K., Verma, N.,
Carter, N., Boyd, R., Tran, G., Hodgkinson, S.
(2008). Studies on naïve CD4+CD25+ T cell
inhibition of naïve CD4+CD25- T cells in mixed
lymphocyte culture. Transplant Immunology,
18(4), 291-301. <a
href="http://dx.doi.org/10.1016/j.trim.2007.09.00
2">[More Information]</a>
2007
Boyd, R., Hodgkinson, S., Carter, N., Tran, G.,
Plain, K., Verma, N., Robinson, C., Hall, B.
(2007). Absence of membrane attack complex
(MAC), delays onset of proteinuria in heymann
nephritis (HN). 43rd Annual Scientific Meeting
of the Australian and New Zealand Society of
Nephrology. Blackwell Synergy.
Verma, N., Plain, K., Tran, G., Boyd, R.,
Hodgkinson, S., Carter, N., Robinson, C., Hall,
B. (2007). Allograft tolerance mediating CD4+T
cells depend upon interferon- gamma (IFN-g) or
interleukin-5 (IL-5). 43rd Annual Scientific
Meeting of the Australian and New Zealand
Society of Nephrology. Blackwell Synergy.
Boyd, R., Hodgkinson, S., Carter, N., Tran, G.,
Plain, K., Verma, N., Robinson, C., Hall, B.
(2007). Complement C6 deficiency in Lewis rats
does not prevent proteinuria in active Heymann
Nephritis. American Society of Nephrology Renal
Week 2007, USA: American Society of
Nephrology.
Davidson, C., Verma, N., Robinson, C., Plain,
K., Tran, G., Hodgkinson, S., Hall, B. (2007).
IL-13 prolongs allograft survival: Association
with inhibition of macrophage cytokine
activation. Transplant Immunology, 17(3),
178-186.
Verma, N., Plain, K., Robinson, C., Boyd, R.,
Tran, G., Carter, N., Hodgkinson, S., Hall, B.
(2007). Th1 and Th2 responses induce separate
lineages of CD4+CD25+T cells that mediate
allograft tolerance. 43rd Annual Scientific
Meeting of the Australian and New Zealand
Society of Nephrology. Blackwell Synergy.
Hall, B., Plain, K., Verma, N., Tran, G., Boyd,
R., Robinson, C., Nicolls, M., Berger, M.,
Nomura, M., Hodgkinson, S. (2007). Transfer of
allograft specific tolerance requires CD4+CD25
+T cells but not interleukin-4 or transforming
growth factor-β and cannot induce tolerance to
linked antigens. Transplantation, 83(8),
1075-1084.
Plain, K., Boyd, R., Verma, N., Robinson, C.,
Tran, G., Hodgkinson, S., Hall, B. (2007).
Transplant tolerance associated with a Th1
response and not broken by IL-4, IL-5, and
TGF-β blockade or Th1 cytokine administration.
Transplantation, 83(6), 764-773.
2006
Hall, B., Plain, K., Robinson, C., Nomura, M.,
Verma, N., Boyd, R., Tran, G., Hodgkinson, S.
(2006). A test to detect specific immune
tolerance to transplanted organs by examining in
vitro reactivity of peripheral CD4+ T cells and
the CD25+ and CD25- subsets. World
Transplant Congress 2006, USA: Blackwell
Publishers.
Verma, N., Plain, K., Nomura, M., Tran, G.,
Robinson, C., Boyd, R., Hodgkinson, S., Hall, B.
(2006). CD4+CD25+ T suppressor cells induced
by short-term culture with IL-2 or IL-4 and
specific alloantigen have increased specific
suppressive capacity both in vitro and in vivo.
World Transplant Congress 2006, USA:
Blackwell Publishers.
Plain, K., Verma, N., Tran, G., Boyd, R.,
Nomura, M., Robinson, C., Hodgkinson, S., Hall,
B. (2006). IL-4 does not maintain specific
tolerance mediating CD4+CD25+ T suppressor
cells but induces antigen-specific naive
CD4+CD25+ T cells. World Transplant
Congress 2006, USA: Blackwell Publishers.
Verma, N., Boyd, R., Robinson, C., Plain, K.,
Tran, G., Hall, B. (2006). Interleukin-12p70
Prolongs Allograft Survival by
Induction of Interferon Gamma and Nitric
Oxide Production. Transplantation, 82(10),
1324-1333.
Nomura, M., Plain, K., Verma, N., Robinson, C.,
Boyd, R., Hodgkinson, S., Hall, B. (2006). The
cellular basis of cardiac allograft rejection. IX.
Ratio of naive CD4+CD25+/CD4+CD25- T cells
determines rejection or tolerance.
Transplantation Proceedings, 15(4), 311-318.
Hodgkinson, S., Nomura, M., Tran, G., Verma,
N., Plain, K., Boyd, R., Hall, B. (2006).
Transplant tolerance mediating CD4+ T cells
contain CD4+CD25+ T cells that express
interferon-gamma receptor and their survival is
promoted by IFN-gamma. World Transplant
Congress 2006, USA: Blackwell Publishers.
Publications for Nirupama Verma
2005
Plain, K., Verma, N., Boyd,, R., Tran, G., Carter,
N., Hodgkinson, S. (2005). IFN-y receptor and
IL-4 receptor expression on CD4+,CD25+
regulatory T cells. Transplantation Society of
Australia.
2002
Plain, K., Robinson, C., Boyd, R., Verma, N.,
Tran, G., Hodgkinson, S., Hall, B. (2002). IL-4
does not maintain the function of specific
CD4+,CD25+ regulatory T cells in allograft
tolerance. Australian Society of Health and
Medical Research.
2001
Hall, B., Chen, J., Robinson, C., He, X., Plain,
K., Verma, N., Hodgkinson, S. (2001).
Conditioned dendritic cells as a temporal bridge
between T helper and cytotoxic cells.
Transplantation Proceedings, 33(1-2), 195-196.